several advantages over natural antibodies and over Phage display of antibody fragments provides a convenient other proteins architectures. Synthetic antibodies format for directed molecular evolution of this biologically im-would not be constrained by tolerance mechanisms opportant protein architecture. Current understanding of the natu-erating on natural antibodies and should retain the ral evolution of antibodies in vivo has allowed their synthesis desirable pharmocokinetics of natural antibodies. and selection in vitro. Synthetic antibodies have been demon-Their creation and selection ex vivo allow their funcstrated to utilize the same mechanisms of molecular recognition tional properties to be expanded beyond simple bindas those used by natural antibodies. The ability to produce syn-ing. With this system we are developing strategies that thetic human antibodies that bind any antigen should eliminate allow the selection of proteins that bind targets or catathe need for animals in the production of monoclonal antibodies. lyze reactions. The linkage of genotype and phenotype via the filamentous phage surface provides a format for rapidly sorting libraries of phage displaying proteins on their surface (1). Phage (the bacterial viruses) can be engineered to display foreign peptide or protein sequences The ability to design proteins that efficiently perform on their coats. Within their coats they contain DNA predefined tasks would have a profound impact on both encoding the displayed sequence incorporated into the scientific investigation and the everyday life of the indi-viral genome. Thus, in phage, a sample of protein is vidual. ''Designer proteins'' might allow the dissection packaged together with the gene that encodes it. Linkof biological pathways and mechanisms, the rapid cre-age in phage libraries has two immediate conseation of new drugs, the efficient use of natural re-quences. First, this linkage allows the selection and sources, and eventually the creation of new organisms amplification of clones from pools of millions. Selection with phenotypes not found in nature. Two considerable is performed by incubating the phage with an immobiproblems that thwart the realization of this goal are lized target, for example on a single well of a microtiter the protein folding problem and the chemistry of cataly-plate. Phage that bind nonspecifically may be washed sis. Our approach has been to develop selective/evolu-away. The highest affinity display phage are then tionary strategies as an alternate route toward ob-eluted with acid, which disrupts the antibody/antigen taining proteins of defined activity. These same union. With filamentous phage, the amplification step strategies may also assist in solving the problems that is accomplished by simply infecting male Escherichia prevent the direct design of proteins. As our model sys-coli, which then produce many more phage. This protem we have chosen antibodies, the most diverse molec-cess is termed panning. Generally the library must be ular recognition system in nature. The development of panned or selected through several cycles in order to synthetic human antibodies as a class of proteins has select the most fit clones. Each cycle allows enrichments of 10 3 -10 5 in specific clones and several cycles of panning allow the highest affinity member(s) of li-
The linkage of genotype and phenotype via the filamentous phage surface provides a format for rapidly sorting libraries of phage displaying proteins on their surface (1) . Phage (the bacterial viruses) can be engineered to display foreign peptide or protein sequences The ability to design proteins that efficiently perform on their coats. Within their coats they contain DNA predefined tasks would have a profound impact on both encoding the displayed sequence incorporated into the scientific investigation and the everyday life of the indi-viral genome. Thus, in phage, a sample of protein is vidual. ''Designer proteins'' might allow the dissection packaged together with the gene that encodes it. Linkof biological pathways and mechanisms, the rapid cre-age in phage libraries has two immediate conseation of new drugs, the efficient use of natural re-quences. First, this linkage allows the selection and sources, and eventually the creation of new organisms amplification of clones from pools of millions. Selection with phenotypes not found in nature. Two considerable is performed by incubating the phage with an immobiproblems that thwart the realization of this goal are lized target, for example on a single well of a microtiter the protein folding problem and the chemistry of cataly-plate. Phage that bind nonspecifically may be washed sis. Our approach has been to develop selective/evolu-away. The highest affinity display phage are then tionary strategies as an alternate route toward ob-eluted with acid, which disrupts the antibody/antigen taining proteins of defined activity. These same union. With filamentous phage, the amplification step strategies may also assist in solving the problems that is accomplished by simply infecting male Escherichia prevent the direct design of proteins. As our model sys-coli, which then produce many more phage. This protem we have chosen antibodies, the most diverse molec-cess is termed panning. Generally the library must be ular recognition system in nature. The development of panned or selected through several cycles in order to synthetic human antibodies as a class of proteins has select the most fit clones. Each cycle allows enrichments of 10 3 -10 5 in specific clones and several cycles of panning allow the highest affinity member(s) of li-Second, a phage displaying a peptide/protein se-both provide a means of producing the antibody in a soluble form. quence that has been selected can be conveniently characterized with respect to amino acid sequence by deciphering the DNA sequence within. True molecular evolution entails selection for activity followed by am-BUILDING SYNTHETIC ANTIBODY plification/mutagenesis and reselection. Phage display REPERTOIRES is currently the best available technique to manipulate populations of proteins. Generally the approach has been performed for simple binding selection; however,
The combining site of an antibody is shown in Fig.  2 . The antibody structure is well suited to both binding as we will see below it can be extended to catalytic selection. The phage display approach has been re-and catalysis. The combining site is formed by the convergence of six hypervariable peptide loops or complecently reviewed and the reader is directed to these reviews for detailed discussion of available systems (3-mentarity determining regions (CDRs). Three CDRs are provided by each heavy (H) and light (L) chain 6). Following selection, the fusion protein that results in phage display may be produced in soluble form or protein, which together, as a heterodimer, form the antibody. In nature, diversity in antibody combining the selected gene encoding the Fab may be subcloned into an expression vector (Fig. 1) . Soluble Fab frag-sites is produced by the combination of multiple variable (V), diversity (D), and joining (J) gene segments ments may then be purified and characterized. Those familiar with the immune system's strategy for select-and somatic mutation. CDRs 1 and 2 of H and L chains are encoded by the V regions. Light chain CDR 3 ing and evolving antibodies will note the features common between a B cell and the phage display of antibod-(LCDR3) is produced by the combination of V and J regions, whereas heavy chain CDR3 (HCDR3) is ies (2) . Both incorporate surface display of the antibody, which allows selection and clonal amplification, and formed by the combination of V, D, and J regions. The
FIG. 1.
Prototypical phage display vectors, pComb3(2) and pComb3H. The vectors contain mouse and human amino-terminal VH sequences, respectively. The surface display version of these vectors contains a heavy Fd fragment fused to a truncated gene 3 protein. A light chain gene is expressed in a soluble form. Both the H chain/gIII and the L chain are targeted to the periplasm by a pelB leader sequence or in the case of pComb3H the light chain is targeted by an omp A leader sequence. gIII is an integral membrane protein and thus acts as a membrane anchor for Fab assembly. Following selection, digestion of pComb3 or pComb3H with the restriction enzymes NheI and SpeI and self ligation of the vector removes the gIII gene. Removal of gene III causes the Fab to be targetted to the periplasm without attachment to gIII. As such the Fab is no longer associated with the bacterial membrane, but is produced in soluble form. Alternatively, Fabs or other proteins may be subcloned into the pAra-HA vector, which adds a decapeptide sequence to the tail of the expressed protein for purification and immunological assays. This vector is conveniently induced with arabinose. Both pComb3H and pAra-HA possess asymmetric SfiI sites that allow directional cloning with a single enzyme. The vectors pComb3H and pAra-HA have been constructed by C.F.B. and Patrick Dillon.
mechanisms for the fusions of the gene segments are this germline light chain is overrepresented in the expressed repertoire (6, 14, 15) . The Humkv325 light complex and in the case of HCDR3 have the potential to generate more than 10 14 peptides in this region, which chain by virtue of its fitness in the natural repertoire seemed an ideal choice for incorporation into a syndiffer in both length and sequence (7) . HCDR3 length may vary from 2 to more than 26 residues (8). The thetic library. HCDR3 of the parent anti-tetanus toxoid was 16 amino acids in length. This region was comselection of antibodies with different binding characteristics in the primary immune response is for the most pletely randomized using a synthetic oligonucleotide with an NNS doping strategy, where N is any of the 4 part dependent on VDJ fusion or creation of the HCDR3. Exceptions include preexisting binding speci-nucleotides and S is G or C. NNS encodes all 20 amino acids and a single amber stop codon in a total of 32 ficities encoded in the V regions and cases in which the light chain dominates the binding. Focused variation codons. In this case the full length of 16 residues was utilized to ensure structural diversity even though such of sequence within the variable domains during the immune response allows the natural evolution of pro-a library would be incomplete, as more than 10 20 clones would be required for every possible sequence to be teins that bind any antigen. Structural stability and the characteristic immunoglobulin fold is provided by represented. The synthetic genes were constructed by PCR and cloned into the phage display vector pComb3 the conserved b-sheet framework that supports the CDRs (9) .
to yield a library of 5 1 10 7 clones, a size on the order of the number of B cells in a mouse. Consideration of the distribution of molecular diversity within natural antibodies led to a strategy for the construction of synthetic antibodies (10, 11). In building the first synthetic antibodies, a repertoire of syn-SELECTION FOR BINDING thetic random HCDR3 sequences was constructed on the backbone of an existing human antibody of defined specificity, an anti-tetanus toxoid antibody. The ratioWith the phage display approach, the library of Fab fragments was selected for binding to either a fluoresnal for limiting diversity to this region was based on the observation that this loop contributes most in terms cein-BSA conjugate or to free fluorescein. Selective pressure for binding free fluorescein was provided by of molecular diversity to the antibody combining site. This antibody was of particular interest because it pos-eluting bound phage with fluorescein. Seven unique clones from the conjugate selection were obtained. The sesses a ''universal light chain.'' The light chain is encoded by the Humkv325 germline sequence and has affinities of these clones were in the 1.5 mM range for free fluorescein and as high as 50 nM for the conjugate been found paired with numerous heavy chains in natural antibodies with many different specificities (12, on which they were selected. Three unique clones were obtained in the selection for binding free fluorescein 13). Repertoire cloning studies support the notion that and the affinities of these were in the 140 nM range for free fluorescein and the 20 nM range for the conjugate. The most striking observation was the appearance of a Ser-Arg-Pro sequence near the central position of the HCDR3 of these three clones. Codon usage suggested that this consensus was the result of selection at the level of the protein and not due to bias in the initial oligonucleotide sequence. Another structurally significant observation was the selection of Asp-101 in the HCDR3. In naturally occurring antibodies Asp-101 has been shown to participate in a structurally important salt bridge with Arg-94, the last residue in FR3. Thus, these synthetic antibodies have recapitulated a structurally conserved feature of natural antibodies, supporting the hypothesis for the role of this conserved sequence. This leads to the suggestion that synthetic antibodies will not be artificial in their character and will be constrained in some extent to sequences found sequence diversity and the role of Asp-101 in the HCDR3. For practical reasons it is very difficult to pre-of synthetic antibodies for magnetite and DNA lend credence to the idea that there may be a non-DNA pare libraries containing more than 10 9 heavy or light chains. This imposes a practical limit on the sequence antigen that elicits the autoimmune antibodies in systemic lupus erythematosus. To date, however, no magdiversity that may be examined. For example, to survey a library with 99% confidence, a library with 6 amino netotactic bacteria have been observed in humans. In all of these selections no clones from the 5-residueacids randomized requires ú10 9 clones. Randomization of 6 residues results in a library diverse in sequences length HCDR3 libraries or libraries of any length where Asp-101 was varied were observed following but constrained in structure. The remodeling of a single combining site to bind a variety of antigens might best analysis of 49 selected clones.
In another study we examined libraries of HCDR3, be achieved by focusing on structural diversity, i.e., randomizing stretches that are longer than can be com-LCDR3, and both together using a competitive selection scheme for the selection of anti-hapten antibodies pletely surveyed, but that display a greater degree of structural freedom. This hypothesis is testable using (19). Selection for binding three different haptens resulted in 18 antihapten antibodies; additional clones a competitive selection scheme. Selection from pooled libraries of antibodies to different antigens would allow were available but were not sequenced. The specificities and binding constants of four of these were examthe highest affinity antibodies from each collection to be isolated. The sequences of the selected antibodies ined and are shown in Fig. 4 . Various degrees of specificity were observed with binding constants between would allow their assignment to a defined library.
As an initial test of this hypothesis and the role of 80 and 29 nM as determined by surface plasmon resonance. Again, no clones from five residue HCDR3s were Asp-101, six HCDR3 libraries of lengths 5, 10, and 16 were constructed. Asp-101 was either fixed or random-selected with the competitive selection scheme. Additionally, none were selected from the LCDR3-only liized. This study focused on developing a strategy for the iterative selection of catalytic antibodies that uti-braries, where a maximum of six residues were randomized. The selected clones were derived mostly from lized metal cofactors. Fabs were selected to bind a variety of metal ions by immobilizing the metal with an HCDR3/LCDR3 libraries. Furthermore, all clones selected were derived from HCDR3 libraries in which iminodiacetic acid support (16) . Success of the selection strategy could be verified with some of the metals, such Asp-101 was fixed. These results support the notion that structurally diverse libraries are a requirement for as Cu 2/ and Zn 2/ , by knowledge of side chains that have been shown to be important in chelating these remodeling a given framework. Extrapolation of these results may be used to rationalize the utilization of metals. The Cu 2/ and Zn 2/ selected clones were abundant in His, Cys, Met, and Asp, as would be predicted. shorter HCDR3 lengths in mice compared with humans (8) . We suggest that structural diversity lacking in Binding to free Cu 2/ was verified by fluorescence quench experiments. The selective panning was also HCDR3 of the mouse may be compensated by its use of a far greater number of V segments. applied to the selection of Fab, which could bind the surface of the metal oxide magnetite. This experiment produced 4 clones that were similar to other loop sequences that had previously been reported to bind magnetite. Comparison of the sequences of the magnetiteselected clones with natural antibodies revealed that these synthetic HCDRs were very similar to well-characterized autoimmune mouse HCDRs known to bind DNA (17). This led to our subsequent testing of the anti-magnetite clones for DNA binding activity. All were shown to bind DNA with good affinity. The sequence similarity between synthetic and natural HCDR3s is shown in Fig. 3 . Note the N-terminal RSK sequence shared by many clones and the stretch of hy- An alternative to a random search of binding sites for the desired specificity is a directed search that inproteins as demonstrated by their ability to form nucleoprotein complexes in electrophoretic mobility shift corporates information known to be relevant to a given binding problem. For anti-receptor antibodies, inforassays. The two Fabs that were characterized contained HCDR3s of 10 and 16 residues in length. Inter-mation relevant to the binding of the ligand to the receptor may be utilized to construct specialized libraries estingly, although the CDRs differed in length, the amino and carboxy ends of the HCDR3 were virtually directed to bind a given receptor or receptor family.
The minimal binding sequences of a number of ligands identical. The clone with the 16-residue HCDR3 demonstrated a clear preference for poly(dGdC)rpo-for their receptors have been characterized. Recently, methodology that allows for the direct design and selecly(dGdC), whereas the other clone bound different oligonucleotides with similar affinity. This observation tion of human antibodies reactive with human receptors has been developed (21) . The overall strategy is and the fact that the two clones differ only in the central portion of HCDR3 suggest that this region is cru-outlined in Fig. 5A . A minimal sequence known to be important for the binding of the ligand to the receptor cial for the sequence preference displayed by one of the clones and may provide the basis for the design and is transplanted into an antibody CDR. Since the correct conformational display of the sequence will in almost selection of antibodies capable of sequence-specific recognition. In unpublished studies these synthetic all cases be critical for interaction with the receptor, the transplanted sequence is flanked by randomized segments that form the elements of diversity within the library. The randomized elements also allow the selection of additional contact residues. As a demonstration of the validity of this approach a member of the Asp-Gly-Arg (RGD) binding integrin receptor family, a V b 3 , was chosen as a target receptor. The simple tripeptide RGD formed the basis for the construction of the library. In this case, the RGD sequence was placed near the apex of the extended hairpin loop of the HCDR3 of a human anti-HIV Fab. The HCDR3 had a moderately long sequence of 18 residues. Residues at the N-and C-terminal of the CDR were conserved to retain the stem of the loop. On each flank of the RGD sequence three randomized residues were inserted. Following selection of the 3 1 10 7 member library for binding to a V b 3 , five Fab clones were characterized. The selected flanking regions showed some homology with known integrin binding peptides; however, some by ELISA against several haptens, as well as tetanus toxoid (the were astonishingly high, 10 010 M. Specificity characteroriginal specificity) and BSA as a background control. The antigens ization revealed that the Fabs also bound a IIb b 3 but not are (from left to right) tetanus toxoid, fluorescein, BSA, a sulfonate-a V b 5 , two integrins highly related to a V b 3 . These three containing hapten, and a coumarin derivative. F22 and P2 were se-integrins can share the same high-affinity ligand lected to bind fluorescein and have dissociation constants of 34 and vitronectin and all bind RGD-containing peptides. Fur-80 nM, respectively. S2, S4, and S10 were selected to bind the sulfonate and have dissociation constants of 29, 56, and 37 nM, respecthermore, a V b 3 and a V b 5 bind with the same affinity tively. C15 was selected to bind the coumarin derivative. F22 is de-to some RGD-containing peptides. Fabs were shown to rived from a library where 16 amino acids of the HCDR3 were compete with RGD peptides for the integrin ligand bind- demonstrated the Fabs to be potent in adhesion assays and subsequently (22) in inhibiting platelet aggregation Synthetic antibodies can also be utilized to derive novel minimal ligands for receptors. Recently it has (Fig. 5B) . Collectively, antagonism of these integrins could have potential in the treatment of osteoporosis and been demonstrated that randomization of the RGDX sequence within the context of the optimized Fab-9 (21) as anti-metastatic and anti-thrombotic agents.
architecture and reselection for a IIb b 3 binding leads to the identification of a number of novel non-RGD ligand sequences within the HCDR3 (22) . This experiment led to the suggestion of a new minimal sequence consensus for a IIb b 3 , namely R/K-X-D, where X is virtually any amino acid except proline. Several of these novel non-RGD Fabs demonstrated the capacity to discriminate between a V b 3 and a IIb b 3 with a maximal difference of 100-fold preference (affinity) for a IIb b 3 . Prospects for the use of these antibodies as lead compounds were examined through the characterization of HCDR3 peptides. Peptides were shown to maintain receptor specificity albeit at reduced affinity.
CDR WALKING: IMPROVING ANTIBODY AFFINITY BY GENE SYNTHESIS AND SELECTION
The systems and mutagenesis strategies described for producing new antibodies can also be utilized to improve the properties of existing antibodies. Several strategies have been applied to improve the affinity of antibody fragments. For all of these studies it is important to consider the affinity range of the antibody to be improved. It is expected and indeed observed that greater relative improvements are more readily ob- An approach termed ''CDR walking'' may prove to then transplanted into a semisynthetic antibody library. The random be a general method for the improvement of antibody sequence is provided to optimize the conformational display of the affinity (23). This approach is a variant of the synthetic transplanted sequence, which will be dependent on constraints imantibody approach with one important difference. In posed by the antibody. Random sequence also allows selection of this case library completeness is stressed over strucadditional contact residues. Selection from a vast library of variants provides the optimal anti-receptor antibody. For integrins that bind tural diversity and randomization is limited to six resi-RGD-containing peptides, the simple RGD sequence is transplanted. dues or less. The approach may be applied in a parallel by an additional six rounds of panning. A clone with an 8-fold improvement of affinity, for a final affinity of tribution and geometry of the fleeting transition state.
Antibodies that bind the analog are expected to stabi-0.7 nM, was isolated. The epitope recognized by this antibody is the CD4-binding domain on gp120. As this lize the transition state. This lowers the activation energy, resulting in catalysis. For acyl-transfer reactions, functional feature, which is not formed by a linear sequence, is retained by all variants of HIV-1, it was which proceed through an anionic tetrahedral transition state, phosphonate analogs provide the best approposed that the affinity of this synthetic antibody should also be increased for divergent HIV isolates. proximation of the anionic and tetrahedral configuration of the transition state. Indeed, acyl-transfer This was tested by determining the affinities of several clones for gp120 derived from MN and IIIB strains. reactions were the first and most successful class of reactions catalyzed by antibodies. Unfortunately, for These proteins differ in over 80 amino acids and are highly divergent. As shown in Fig. 6 , the affinity in-many reactions, analogs that faithfully mimic the transition state are not chemically feasible and transition creases for both gp120s are well correlated. Functional improvement was assayed in virus neutralization stud-state stabilization is only one of several mechanisms to affect catalysis. As a result the rate accelerations ies with laboratory isolates and a 54-fold improvement was determined for the highest affinity clone. Further-achieved by antibodies are in most cases several orders of magnitude lower than those realized by their natural more, neutralization studies with primary clinical isolates demonstrated that the improved Fab acquired the enzyme counterparts. For demanding reactions such as amide bond hydrolysis that require two or more comability to neutralize additional variants not neutralized by the parent. Further application of the CDR walking plementary functionalities correctly positioned in the enzymatic binding pocket, little success has been strategy has allowed for the selection of Fabs with affinities of 10 012 M.
achieved.
The direct selection of catalytic Fabs from phage display libraries was proposed in our original Fab display report (2) . The strategy proposed was to use mecha-
SELECTION FOR CATALYSIS
nism-based inhibitors or affinity labels to select for appropriately positioned functionalities within the comSince 1986, a large number of catalytic antibodies bining site of an antibody. These functionalities, amino have been prepared by immunization of mice with hap-acid side chains with the appropriate chemical charactens that mimic the putative transition state of the teristics and geometries, would then catalyze a chemichosen reaction (25). Transition-state analogs are sta-cal reaction with the appropriate substrate. Synthetic ble molecules designed to approximate the charge dis-antibodies and directed molecular evolution provide additional opportunities for the selection of catalytic proteins. For example, iterative selection could improve catalysis by successive selection with different haptens that embody partial features of the ideal analog. This would circumvent the challenge of incorporating into a single hapten the features that might induce all of the mechanisms (transition-state stabilization, general acid-base catalysis, cofactors, proximity effects, etc.) used by natural enzymes to produce catalysis. Iterative selection strategy may be best applied following primary selection with a transition-state analog. Secondary selections would focus on recruiting and refining the placement of amino acid side chains in the binding pocket. A fundamental advantage of the library methodology is the ability to use haptens carrying sensitive functional groups that would be rapidly degraded using the traditional immunization approach. This feature opens the door for mechanism-based haptens. Mechanism-based haptens allow the direct selection of a particular chemical event. In principle, any of the  FIG. 6 . The affinity increases of evolving Fabs for binding the di-well-documented mechanism-based inhibitors could be vergent envelope proteins gp120 IIIB (LAI) and gp120 MN are well applied to select for at least part of the chemical mechacorrelated. Affinities were determined using the surface plasmon nism (26) . In such an approach, the hapten, linked the antibody library. Those members capable of trans-forming the hapten into a reactive species form a cova-fide bond were selectively released by reduction of the disulfide following elution with acid of noncovalently lent bond with the hapten. Others are washed off. The next step requires cleavage of the linker to allow recov-attached phage. Sequencing of 10 of the selected Fabs revealed 2 with unpaired cysteines. One of these was ery of the desired antibody before amplification. If necessary, one or several rounds of such panning can be examined for its ability to hydrolyze a thiol ester substrate, designed to place the electrophilic center of the performed (Fig. 7,22) . Two different functionalities are commonly used as cleavable units in protein linkage: carbonyl in the position of original active disulfide of the affinity label. The Fab was shown to be catalytic a disulfide (27) or a diol (28) that can be cleaved under reducing (NaBH 4 ) or oxidizing (NaIO 4 ) conditions, re-in its hydrolysis of the ester and was further characterized to proceed through a covalent intermediate. Thus, spectively.
Preliminary investigations have utilized a pyridyl di-the catalytic activity had been directly selected to proceed through the mechanism dictated by the design of sulfide affinity label to trap an appropriately positioned thiol in the active site of a synthetic antibody (29) . the affinity label/substrate pair. This is the first report of the selection of a catalytic protein, in this case an Phage that covalently bound to the support via a disulFab, from a random protein library and will likely have a major impact on the field of catalytic antibodies. A more complex scheme for the selection of two elements of a protease catalytic triad is outlined below. Compounds (a) and (b) have been recently synthesized in our laboratories (see legend, Fig. 8 ). Each dipeptide (Ala-Phe and His-Phe) is attached at one end to a cleavable linker, whereas the other extremity is occupied by a diazoketone functionality. Peptidyl diazomethyl ketones have been shown by Shaw et al.
(30) to be specific inhibitors of thiol proteinases, being unreactive toward other classes of proteinases as well as thiols such as mercaptoethanol and glutathione. Their ability to select specifically cysteine residues located in the binding pocket of enzymes is unique, as even the closely related halomethyl ketones (chloro or bromo) do not permit a distinction between serine and cysteine proteinases. The mechanism of inactivation of FIG. 7. Panning for covalent trapping. A diverse library of Fabexpressing phage is applied to an immobilized target. Several hours are allowed for a binding equilibrium to be reached, and then nonbinding phage are washed from the solid support. Specifically bound phage can be eluted at low pH or by the addition of soluble antigen. Phage that bind via a covalent interaction with the mechanism-based inhibitor or affinity label are collected by cleavage of the designed linker sequence. Cleavage may be accomplished using reductive or FIG. 8 . Mechanism-based selection with peptidyl diazomethyl ketones for proteins with esterase and amidase activity (31) . R is oxidative conditions as dictated by the linker construction. Covalently selected phage are amplified for further rounds of selection by linker-Ala-Phe for (a) and linker-His-Phe for (b); see text. The proposed mechanism of selection for an activated thiol of a cysteine infection of E. coli followed by helper phage rescue. One ''round'' of panning (from isolation of a pool of phage to amplification of selected residue is shown. This selection scheme would provide two elements of a protease's catalytic triad to be selected directly from a library clones) takes 1 day. Several rounds are generally performed to minimize the presence of nonspecific binding clones, which should be of antibodies displayed on phage. If selection occurs by route (2) , then stabilization of the tetrahedral intermediate is also expected. eliminated following several rounds of panning.
papain by diazomethyl ketones has been thoroughly ACKNOWLEDGMENTS described by Brocklehurst and Malthouse (31) . Papain is a thiol proteinase containing, among others, a cys- group by the neighboring histidine residue and rearrangement (Fig. 8) . Since it has yet to be unambigu-
